Document is current
Any future updates will be listed below
-
Authors
Pitsillou, Eleni
Bresnehan, Sarah M.
Kagarakis, Evan A.
Wijoyo, Stevano J.
Liang, Julia
Hung, Andrew
Karagiannis, Tom C.
- License Information
-
More Information
Article History
Received: 19 July 2019
Accepted: 9 October 2019
First Online: 14 October 2019
Compliance with ethical standards
:
: Although there is no direct conflict of interest with respect to this manuscript, the Epigenomic Medicine Program (TCK) is supported financially by McCord Research (Iowa, USA), which has commercial interests in nutraceuticals, some of which may be beneficial for depression. The remaining co-authors have no conflicts of interest.
